Francesca Santilli has been a Full Professor of Internal Medicine at the University of Chieti since 2015. She has also been Head of the Haemostasis and Thrombosis Unit, Center for Advanced Studies
and Technology, Chieti since 2017 and Chief of the Diabetes Clinic in Chieti
University Hospital. Her main topics of interest involve preventive cardiology
and diabetes mellitus and its complications. She is co-author of more than 140
original articles and book chapters. She has long-term expertise in the
pathophysiology of atherothrombosis, in the context of metabolic and
cardiovascular diseases. Her scientific production encompasses
pathophysiological and clinical pharmacology studies addressing interindividual
variability in low-dose aspirin response, its determinants and therapeutic
strategies. Her know-how includes in vivo biochemical evaluation of thromboxane
metabolite excretion as well as isoprostane formation, and characterization of
platelet proteins.
Research Keywords & Expertise
Diabetes
Obesity
Oxidative Stress
Aspirin
Platelet Activation
Platelet inhibition
Fingerprints
40%
Diabetes
36%
Platelet Activation
29%
Oxidative Stress
23%
Aspirin
16%
Obesity
5%
Platelet inhibition
Short Biography
Francesca Santilli has been a Full Professor of Internal Medicine at the University of Chieti since 2015. She has also been Head of the Haemostasis and Thrombosis Unit, Center for Advanced Studies
and Technology, Chieti since 2017 and Chief of the Diabetes Clinic in Chieti
University Hospital. Her main topics of interest involve preventive cardiology
and diabetes mellitus and its complications. She is co-author of more than 140
original articles and book chapters. She has long-term expertise in the
pathophysiology of atherothrombosis, in the context of metabolic and
cardiovascular diseases. Her scientific production encompasses
pathophysiological and clinical pharmacology studies addressing interindividual
variability in low-dose aspirin response, its determinants and therapeutic
strategies. Her know-how includes in vivo biochemical evaluation of thromboxane
metabolite excretion as well as isoprostane formation, and characterization of
platelet proteins.